Clinical Trials Browser

Phase 2 × Terminated × Sarcoma, Kaposi × Clear all

NCT01412515 2012-01-02

A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma

Phase 2 Terminated

Sarcoma, Kaposi

NCT00127569 2007-01-12

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

Phase 2 Terminated

LymphoidSarcoma

Castleman Disease, Sarcoma, Kaposi, HIV Infections